Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B025c60a0ca30317dcb2b22d79c45a3b6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B025c60a0ca30317dcb2b22d79c45a3b6 NCIT_P378 "NCI" @default.
- B025c60a0ca30317dcb2b22d79c45a3b6 type Axiom @default.
- B025c60a0ca30317dcb2b22d79c45a3b6 annotatedProperty IAO_0000115 @default.
- B025c60a0ca30317dcb2b22d79c45a3b6 annotatedSource NCIT_C168775 @default.
- B025c60a0ca30317dcb2b22d79c45a3b6 annotatedTarget "A therapeutic cancer vaccine composed of autologous, dendritic cells (DCs) that have been loaded with a proprietary selection of four antigens that covers more than ninety percent of all non-small cell lung cancer (NSCLC) patients, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous tetravalent dendritic cell vaccine MIDRIX4-LUNG may induce and stimulate both T-helper and antigen-specific cytotoxic T-lymphocyte (CTL) responses, leading to tumor cell lysis in patients with NSCLC." @default.